Chloramphenicol/OVA is an antigen-adjuvant conjugate formed by linking Chloramphenicol with chicken ovalbumin (OVA). This conjugation enhances the production of antigen-specific antibodies in vaccine models. The conjugate does not alter protein folding or disrupt primary epitopes, and it can augment cross-presentation and the generation of antigen-specific T cells.